SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
妍宝贝
Lv1
80 积分
2023-09-17 加入
最近求助
最近应助
互助留言
Treatment satisfaction with ITCA 650, a novel drug‐device delivering continuous exenatide, versus twice‐daily injections of exenatide in type 2 diabetics using metformin
12天前
已完结
Clinical Use of Liraglutide in Type 2 Diabetes and its Effects on Cardiovascular Risk Factors
13天前
已完结
Five-Year Efficacy and Safety Data of Exenatide Once Weekly
20天前
已完结
Evaluation of Patient-Reported Satisfaction and Clinical Efficacy of Once-Weekly Semaglutide in Patients with Type 2 Diabetes: An Ambispective Study
20天前
已完结
GLP‐1 receptor agonist added to insulin versus basal‐plus or basal‐bolus insulin therapy in type 2 diabetes: A systematic review and meta‐analysis
1个月前
已完结
Switching from subcutaneous to oral semaglutide in type 2 diabetes: A prospective study
1个月前
已完结
Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 1 study)
1个月前
已完结
Evaluation of Patient-Reported Satisfaction and Clinical Efficacy of Once-Weekly Semaglutide in Patients with Type 2 Diabetes: An Ambispective Study
1个月前
已完结
Utilization patterns of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus in Germany: a retrospective cohort study
2个月前
已完结
Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) Trials
2个月前
已完结
没有进行任何应助
点赞
12天前
帮大忙了
13天前
点赞
20天前
速度真快
20天前
帮大忙了
1个月前
帮大忙了
1个月前
速度真快
1个月前
么么哒
1个月前
帮大忙了
2个月前
么么哒
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论